Innovo Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $13.9M

  • Investors
  • 10

Innovo Therapeutics General Information

Description

Developer of novel protein degrader drugs intended for cancer treatment. The company's drugs focus on anti-cancer drugs with targeted protein degradation technology used in the field of targeted protein degradation, enabling healthcare providers to leverage more innovative and effective tumor treatment drugs.

Contact Information

Website
www.innovotherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10355 Science Center Drive
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 10355 Science Center Drive
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 01-Dec-2023 $13.9M Completed Generating Revenue
1. Seed Round 13-May-2022 Completed Startup
To view Innovo Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Innovo Therapeutics Patents

  • 71

    Total Documents Applications and Grants

  • Total Patents Families

  • 36

    Granted

  • 21

    Pending

  • Expiring in next 12 mo

Innovo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026216873-A1 Pyrazolopyridine derivative compounds and uses thereof Pending 10-Apr-2025
EP-4836960-A1 Compositions and methods for degrading aryl hydrocarbon receptor nuclear translocator protein Pending 06-Jan-2025
WO-2026106389-A1 Nmt inhibitor and use thereof Pending 15-Nov-2024
WO-2025245178-A1 Pak4, cstf2, or cstf2t protein degraders, pharmaceutical compositions, and therapeutic applications Pending 21-May-2024
WO-2025179161-A1 Protein degrading compounds Pending 21-Feb-2024 C07D401/14
To view Innovo Therapeutics’s complete patent history, request access »

Innovo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Innovo Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Financial Strategy Investment Holdings Venture Capital Minority
Gandao Investment Holding Company Asset Manager Minority
Hainan Longmen Venture Capital Minority
Huajin Investment Venture Capital Minority
Zhongjince Investment Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Innovo Therapeutics FAQs

  • When was Innovo Therapeutics founded?

    Innovo Therapeutics was founded in 2020.

  • Where is Innovo Therapeutics headquartered?

    Innovo Therapeutics is headquartered in San Diego, CA.

  • What is the size of Innovo Therapeutics?

    Innovo Therapeutics has 11 total employees.

  • What industry is Innovo Therapeutics in?

    Innovo Therapeutics’s primary industry is Drug Discovery.

  • Is Innovo Therapeutics a private or public company?

    Innovo Therapeutics is a Private company.

  • What is Innovo Therapeutics’s current revenue?

    The current revenue for Innovo Therapeutics is .

  • How much funding has Innovo Therapeutics raised over time?

    Innovo Therapeutics has raised $29.1M.

  • Who are Innovo Therapeutics’s investors?

    China Financial Strategy Investment Holdings, Gandao Investment Holding Company, Hainan Longmen, Huajin Investment, and Zhongjince Investment are 5 of 10 investors who have invested in Innovo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process